lung cancer
Conditions
Interventions
RT group:No
Sponsors
Tianjin Medical University Cancer Institute and Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Sign the informed consent form. 2) Be aged 18 years or above and not more than 80 years old. 3) Have a KPS score of 70 or above and an expected survival period of more than 6 months. 4) Be histologically or pathologically diagnosed with lung malignancy. 5) The planned radiotherapy site has not received radiotherapy before or it has been more than 6 months since the last radiotherapy. 6) Be able to complete radiotherapy and have follow-up conditions.
Exclusion criteria
Exclusion criteria: 1) Patients with chronic obstructive pulmonary disease. 2) Patients with metabolic comorbidities (such as obesity, dyslipidemia, etc.) and respiratory disorders (such as poorly controlled diabetes). 3) Patients with other serious diseases who cannot complete treatment or have an expected survival period of less than 3 months. 4) Currently having active tuberculosis or having infections such as pneumonia. 5) Pregnant or lactating patients. 6) Patients with a known history of human immunodeficiency virus (HIV) infection. 7) Patients who have received solid organ or hematopoietic system transplantation. 8) Currently participating in other clinical trials or having participated within 4 weeks. 9) Other situations where the reviewer deems there are sufficient reasons to be unqualified from the registered study: such as potential situations that do not conform to the clinical protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| efficacy evaluation;radiation pneumonitis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression Free Survival;Overall Survival;haematotoxicity; | — |
Countries
China
Contacts
Public ContactZhao Lujun
Tianjin Medical University Cancer Institute and Hospital
Outcome results
None listed